Erweiterte
Suche ›

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

Springer Berlin,
Buch
197,94 € Lieferbar in 2-3 Tagen
Dieses Produkt ist auch verfügbar als:

Kurzbeschreibung

Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine.

Details
Schlagworte

Titel: Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
Autoren/Herausgeber: Larry J. Anderson, Barney S. Graham (Hrsg.)
Aus der Reihe: Current Topics in Microbiology and Immunology
Ausgabe: Softcover reprint of the original 1st ed. 2014

ISBN/EAN: 9783662521557

Seitenzahl: 409
Format: 23,5 x 15,5 cm
Produktform: Taschenbuch/Softcover
Gewicht: 646 g
Sprache: Englisch

buchhandel.de - Newsletter
Möchten Sie sich für den Newsletter anmelden?


Bitte geben Sie eine gültige E-Mail-Adresse ein.
Lieber nicht